Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neuroblastoma 2Rhabdomyosarcoma 1Recurrence 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Desmoplastic Small Round Cell Tumor 1

Interventions

Magnetic Resonance Spectroscopy 3AZD 6244 3fludarabine phosphate 2Specimen Handling 2Nivolumab 2Etoposide 2thymoglobulin 1pembrolizumab 1lorvotuzumab mertansine 1fludarabine 1X-Rays 1Trabectedin 1Thiotepa 1Tacrolimus 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy 1Photons 1Neurofibromin 1 1Mycophenolic Acid 1Mesna 1Melphalan 1Liquid Biopsy 1Ipilimumab 1Imatinib Mesylate 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibrosarcoma × Cyclosporins × CNS × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡